Yuen K, Johannsson G, Ho K, Miller B, Bergada I, Rogol A
Endocr Connect. 2023; 12(7).
PMID: 37052176
PMC: 10305501.
DOI: 10.1530/EC-22-0504.
Lin Y, Thomas S
J Mass Spectrom Adv Clin Lab. 2023; 28:30-34.
PMID: 36865788
PMC: 9971545.
DOI: 10.1016/j.jmsacl.2023.02.001.
Motorykin I, Li A, Wu Z
Methods Mol Biol. 2022; 2546:239-251.
PMID: 36127594
DOI: 10.1007/978-1-0716-2565-1_22.
Larkey N, Fatica E, Singh R
Methods Mol Biol. 2022; 2546:227-237.
PMID: 36127593
DOI: 10.1007/978-1-0716-2565-1_21.
Cowan D, Moncrieffe D
Drug Test Anal. 2021; 14(5):808-819.
PMID: 34418311
PMC: 9545871.
DOI: 10.1002/dta.3155.
An antibody-free LC-MS/MS method for the quantification of intact insulin-like growth factors 1 and 2 in human plasma.
Pratt M, van Faassen M, Remmelts N, Bischoff R, Kema I
Anal Bioanal Chem. 2021; 413(8):2035-2044.
PMID: 33569646
PMC: 7943504.
DOI: 10.1007/s00216-021-03185-y.
Improving Science by Overcoming Laboratory Pitfalls With Hormone Measurements.
Hillebrand J, Wickenhagen W, Heijboer A
J Clin Endocrinol Metab. 2020; 106(4):e1504-e1512.
PMID: 33382880
PMC: 7993596.
DOI: 10.1210/clinem/dgaa923.
Clinical Mass Spectrometry in the Bioinformatics Era: A Hitchhiker's Guide.
Chong Y, Ho C, Leung S, Lau S, Woo P
Comput Struct Biotechnol J. 2018; 16:316-334.
PMID: 30237866
PMC: 6138949.
DOI: 10.1016/j.csbj.2018.08.003.
Utility of serum IGF-1 for diagnosis of growth hormone deficiency following traumatic brain injury and sport-related concussion.
Lithgow K, Chin A, Debert C, Kline G
BMC Endocr Disord. 2018; 18(1):20.
PMID: 29609574
PMC: 5879553.
DOI: 10.1186/s12902-018-0247-1.
Discordance between mass spectrometry and immunometric IGF-1 assay in pituitary disease: a prospective study.
Bonert V, Carmichael J, Wu Z, Mirocha J, Perez D, Clarke N
Pituitary. 2017; 21(1):65-75.
PMID: 29218459
DOI: 10.1007/s11102-017-0849-z.
Assuring Consistent Performance of an Insulin-Like Growth Factor 1 MALDImmunoassay by Monitoring Measurement Quality Indicators.
Klont F, Ten Hacken N, Horvatovich P, Bakker S, Bischoff R
Anal Chem. 2017; 89(11):6188-6195.
PMID: 28467045
PMC: 5463271.
DOI: 10.1021/acs.analchem.7b01125.
Serum Insulin-like Growth Factor I Quantitation by Mass Spectrometry: Insights for Protein Quantitation with this Technology.
Kam R, Ho C, Chan M
EJIFCC. 2017; 27(4):318-330.
PMID: 28149264
PMC: 5282915.
Mass spectrometry-based approaches to targeted quantitative proteomics in cardiovascular disease.
Mesaros C, Blair I
Clin Proteomics. 2016; 13:20.
PMID: 27713681
PMC: 5050566.
DOI: 10.1186/s12014-016-9121-1.
Reference Values for IGF-I Serum Concentrations: Comparison of Six Immunoassays.
Chanson P, Arnoux A, Mavromati M, Brailly-Tabard S, Massart C, Young J
J Clin Endocrinol Metab. 2016; 101(9):3450-8.
PMID: 27167056
PMC: 5054194.
DOI: 10.1210/jc.2016-1257.
